Viralgen and Axovia Join Forces for Gene Therapy Development for Retinal Dystrophy Viralgen and Axovia are collaborating to manufacture an investigational gene therapy targeting retinal dystrophy in Bardet-Biedl Syndrome patients.

Viralgen and Axovia Join Forces for Gene Therapy Development for Retinal Dystrophy #Spain #San_Sebastián #Viralgen #Axovia #BBS